American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$493M |
| 2 |
Colgate-Palmolive
CL
|
+$367M |
| 3 |
Microsoft
MSFT
|
+$328M |
| 4 |
Fidelity National Information Services
FIS
|
+$298M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WP
Worldpay, Inc.
WP
|
+$300M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$268M |
| 3 |
Medtronic
MDT
|
+$233M |
| 4 |
Intercontinental Exchange
ICE
|
+$201M |
| 5 |
STI
SunTrust Banks, Inc.
STI
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.66% |
| 2 | Technology | 16% |
| 3 | Healthcare | 15% |
| 4 | Consumer Discretionary | 11.58% |
| 5 | Industrials | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AERI
951
DELISTED
Aerie Pharmaceuticals
AERI
| $2.22M | ﹤0.01% |
115,720
+6,985
| +6% | +$160K |
|
952
Regenxbio
RGNX
$720M
| $2.22M | ﹤0.01% |
62,275
+3,626
| +6% | +$147K |
|
953
First Commonwealth Financial
FCF
$2.18B
| $2.22M | ﹤0.01% |
166,837
+50,331
| +43% | +$652K |
|
|
GHDX
954
DELISTED
Genomic Health, Inc.
GHDX
| $2.22M | ﹤0.01% |
32,676
-68,284
| -68% | -$4.69M |
|
955
Mettler-Toledo International
MTD
$28.8B
| $2.19M | ﹤0.01% |
3,114
+28
| +0.9% | +$20.6K |
|
956
Innoviva
INVA
$1.5B
| $2.17M | ﹤0.01% |
205,386
-90,333
| -31% | -$1.08M |
|
957
Viking Therapeutics
VKTX
$3.97B
| $2.16M | ﹤0.01% |
313,656
+18,918
| +6% | +$141K |
|
958
Vistra
VST
$49.2B
| $2.12M | ﹤0.01% |
+79,181
| New | +$1.88M |
|
959
Tredegar Corp
TG
$281M
| $2.09M | ﹤0.01% |
107,101
+40,188
| +60% | +$705K |
|
|
CIT
960
DELISTED
CIT Group Inc.
CIT
| $2.09M | ﹤0.01% |
46,110
+22,901
| +99% | +$1.07M |
|
961
Telephone and Data Systems
TDS
$3.82B
| $2.08M | ﹤0.01% |
80,594
-75,800
| -48% | -$2.12M |
|
962
Franklin Electric
FELE
$4.75B
| $2.06M | ﹤0.01% |
43,096
+24
| +0.1% | +$1.11K |
|
963
iShares MSCI Brazil ETF
EWZ
$8.57B
| $2.04M | ﹤0.01% |
48,309
-1,451
| -3% | -$62.6K |
|
964
Lantheus
LNTH
$6.57B
| $2.03M | ﹤0.01% |
81,151
+59,325
| +272% | +$1.46M |
|
|
DRNA
965
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $2.01M | ﹤0.01% |
139,683
-54,847
| -28% | -$784K |
|
|
WBA
966
DELISTED
Walgreens Boots Alliance
WBA
| $2M | ﹤0.01% |
36,142
+102
| +0.3% | +$5.47K |
|
967
Flowers Foods
FLO
$1.52B
| $1.96M | ﹤0.01% |
84,795
+72,251
| +576% | +$1.67M |
|
968
Caterpillar
CAT
$393B
| $1.95M | ﹤0.01% |
15,434
-481,685
| -97% | -$61.2M |
|
969
iShares Russell 2000 ETF
IWM
$82.2B
| $1.95M | ﹤0.01% |
12,859
+8,059
| +168% | +$1.23M |
|
|
MRTX
970
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $1.93M | ﹤0.01% |
24,807
+1,434
| +6% | +$135K |
|
|
AMJ
971
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
| $1.92M | ﹤0.01% |
+82,669
| New | +$2M |
|
|
ARQL
972
DELISTED
Arqule Inc
ARQL
| $1.92M | ﹤0.01% |
268,090
+16,315
| +6% | +$153K |
|
973
Genesco
GCO
$391M
| $1.92M | ﹤0.01% |
47,940
-99,076
| -67% | -$3.82M |
|
974
Stoke Therapeutics
STOK
$2.13B
| $1.91M | ﹤0.01% |
88,755
-16,128
| -15% | -$450K |
|
975
Stratasys
SSYS
$767M
| $1.9M | ﹤0.01% |
89,148
-89,114
| -50% | -$2.25M |
|
Similar funds
American Century Companies's Q3 2019 Portfolio in Review
As of Q3 2019, American Century Companies held 1,407 positions worth $99.6B, down 0.83% from $100B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
American Century Companies's Q3 2019 filing shows 144 new, 546 increased, 497 reduced and 204 closed positions. Its largest new stake was A.O. Smith: 2,750,567 shares worth $131M. The largest sale was Worldpay, Inc., an estimated $300M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
- American Century Companies's largest Q3 2019 buy was A.O. Smith: 2,750,567 shares worth $131M.
- American Century Companies added most to Pfizer in Q3 2019, an estimated $493M increase.
- American Century Companies's biggest Q3 2019 reduction was Medtronic, cutting an estimated $233M.
- American Century Companies fully exited Worldpay, Inc. in Q3 2019, selling an estimated $300M.
- American Century Companies's ten largest holdings make up 18% of its $99.6B portfolio in Q3 2019.
- American Century Companies opened 144 new positions and closed 204 in Q3 2019.
- American Century Companies's portfolio value fell 0.83% quarter-over-quarter to $99.6B.
Based on American Century Companies's 13F filing for Q3 2019, filed 13 Nov 2019.